In conclusion, miR-382-5p plays an oncogenic role in breast cancer initiation and progression by directly targeting and repressing RERG, thereby activating the Ras/ERK pathway to promote cancer cell viability, clonogenicity, survival, migration, invasion and in vivo tumorigenesis/metastasis. Here, RERG is linked to breast carcinoma.